{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-004320","form_type":"8-K","ticker":"SIGY","cik":"0001642159","company_name":"Sigyn Therapeutics, Inc.","filed_at":"2024-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.950489+00:00","generated_at":"2026-06-06T15:02:50.129362+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Sigyn Therapeutics effects 1-for-40 reverse stock split effective Jan 31, 2024","bullets":["Reverse stock split ratio of 1-for-40 effective 12:01 a.m. ET on January 31, 2024.","Post-split shares outstanding ~1,221,043; pre-split shares were ~48.8 million.","No fractional shares; holders rounding up to next whole share automatically.","All outstanding equity awards and warrants proportionately adjusted for the split ratio.","New CUSIP number is 82674U 205; trading symbol remains SIGY."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-004320","json":"https://secwatch.observer/filing/0001493152-24-004320.json","markdown":"https://secwatch.observer/filing/0001493152-24-004320.md","text":"https://secwatch.observer/filing/0001493152-24-004320.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642159/000149315224004320/0001493152-24-004320-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642159/000149315224004320/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T15:02:50.129362+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c518414461c088580937e224b21f4a6001f4c734","claim":"Sigyn Therapeutics, Inc.: Filing of Certificate of Amendment to Amended and Restated Certificate of Incorporation to effect a 1-for-40 reverse stock split, effective January 31, 2024 (effective 2024-01-31).","evidence_excerpt":"On January 23, 2024, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) effecting a reverse stock split as of 12:01 a.m. Eastern Standard Time on January 31, 2024 with a ratio of 1-for-40 (the “Reverse Split”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642159/000149315224004320/0001493152-24-004320-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-01-31"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}